Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Low Anterior Resection Syndrome 1Gastroparesis 1Esophageal Neoplasms 1Esophageal Motility Disorders 1Esophageal Diseases 1Esophageal Achalasia 1

Interventions

Surveys and Questionnaires 2Interviews as Topic 2citric acid, ispaghula husk, sodium bicarbonate drug combination 1X-Rays 1Vi-siblin 1Surgical Procedures, Operative 1Radiotherapy 1Psyllium 1Physical Therapy Modalities 1Phantoms, Imaging 1Loperamide 1Leucine-tRNA Ligase 1Exercise 1Enema 1Electroacupuncture 1Drinking Water 1Dietary Fiber 1Device Removal 1Consolidation Chemotherapy 1Chemoradiotherapy 1Botulinum Toxins, Type A 1Biofeedback, Psychology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Low Anterior Resection Syndrome × Botulinum Toxins, Type A × Gastrointestinal × Clear all
NCT01589471 2018-02-12

The Value of Botox-A for Management of Low Anterior Resection Syndrome

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Completed
23 enrolled
Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡